Golimumab monotherapy in Japanese patients with active rheumatoid arthritis despite prior treatment with disease-modifying antirheumatic drugs: results of the phase 2/3, multicentre, randomised, double-blind, placebo-controlled GO-MONO study through 24 weeks.

导出 OA

翻译打印收藏纠错

作者： Tsutomu,Takeuchi ^[1] ; Masayoshi,Harigai ; Yoshiya,Tanaka ; Hisashi,Yamanaka ; Naoki,Ishiguro ; Kazuhiko,Yamamoto ; Nobuyuki,Miyasaka ; Takao,Koike ; Minoru,Kanazawa ; Takuya,Oba ; Toru,Yoshinari ; Daniel,Baker ; GO-MONO study group

作者单位： Division of Rheumatology, Keio University, Shinjuku-ku, Tokyo, Japan. tsutake@z5.keio.jp ^[1]

关键词 Anti-TNF Rheumatoid Arthritis Treatment

主题词成年人(Adult);老年人(Aged);抗体, 单克隆(Antibodies, Monoclonal);抗风湿药(Antirheumatic Agents);关节炎, 类风湿(Arthritis, Rheumatoid);剂量效应关系, 药物(Dose-Response Relationship, Drug);双盲法(Double-Blind Method);抗药性(Drug Resistance);女(雌)性(Female);健康状况(Health Status);人类(Humans);男(雄)性(Male);中年人(Middle Aged);疾病严重程度指数(Severity of Illness Index);治疗结果(Treatment Outcome);青年人(Young Adult)

DOI 10.1136/annrheumdis-2012-201796

PMID 22984173

发布时间 2022-04-09

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览51

Annals of the rheumatic diseases

2013年72卷9期

1488-95页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Golimumab monotherapy in Japanese patients with active rheumatoid arthritis despite prior treatment with disease-modifying antirheumatic drugs: results of the phase 2/3, multicentre, randomised, double-blind, placebo-controlled GO-MONO study through 24 weeks.

Annals of the rheumatic diseases

相似文献

Annals of the rheumatic diseases

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Golimumab monotherapy in Japanese patients with active rheumatoid arthritis despite prior treatment with disease-modifying antirheumatic drugs: results of the phase 2/3, multicentre, randomised, double-blind, placebo-controlled GO-MONO study through 24 weeks.

Annals of the rheumatic diseases

相似文献

Annals of the rheumatic diseases

相关期刊

检索历史清除